ALIM Alimera Sciences: Earnings growth forecast for next year

Alimera Sciences Inc (ALIM) - corporate logo

Alimera Sciences (ALIM) stands out with its innovative ILUVIEN micro-implant for retinal therapy, which replaces frequent injections. The company's EPS forecast trends for the coming year on the GURU.Markets terminal linear chart reflect evolving expectations, where the 249.40 mark indicates the current state. The development of ophthalmological agents strictly adheres to FDA standards, while experienced management consistently increases the business's operating margin.

Alimera Sciences Inc (ALIM): Net earnings per share growth forecast for next year from 07/04/2022 to 09/21/2024

Analytical breakdowns for Alimera Sciences

- price and consensus price forecast:
Price Chart Alimera Sciences, Inc.|ALIM - Analyst Median Target
- company stock capitalization data:
Market Capitalization Alimera Sciences, Inc.|ALIM - Enterprise Value
- book capitalization indicators:
Net Assets per Single Share Alimera Sciences|ALIM - Company Book Value|Market Capitalization to Book Value Ratio alimerasciences.com|ALIM - Company Total Asset Base
- debt and liquidity details:
Debt to Equity Alimera Sciences|ALIM - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Alimera Sciences Inc|ALIM - Company Cumulative Debt|Debt to Book Capitalization Ratio Alimera|ALIM - Company Long-Term Loans and Borrowings|Company Short-Term Debts Alimera Sciences|Quick Liquidity Indicator alimerasciences.com
- net income and valuation ratios data:
ALIM - Final Profit|Expected Profit Alimera Sciences|ALIM - Business Payback Period|Forward P/E Multiple alimerasciences.com|ALIM - Price/Earnings to Growth Multiple|EV/EBITDA Multiple ALIM|ALIM - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Alimera Sciences|ALIM - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months alimerasciences.com|ALIM - Earnings per share growth this year|Earnings growth forecast for next year Alimera Sciences
- company sales and revenue statistics:
ALIM - Company Sales|Projected Sales Volume Alimera Sciences Inc|ALIM - Price to Sales|Price-to-Projected Revenue Ratio ALIM
Fundamental company analysis:ALIM, Alimera Sciences Inc
Core merchandise of Alimera Sciences, Inc.

This indicator measures the consensus earnings per share (EPS) forecast, allowing for an assessment of margin expansion potential and the business's credit resilience. By analyzing the next year's EPS forecast trends for Alimera Sciences (ALIM), an investor can mitigate the risks of single-product dependence on a single implant by tracking how integration into a diversified network transforms market expectations into actual yield growth.

Competitor analysis for Alimera Sciences

ALC (Alcon Corp) - Earnings growth forecast for next year|Bausch + Lomb Corporation (BLCO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GKOS|Earnings growth forecast for next year Apellis Pharmaceuticals, Inc. (APLS)|Earnings growth forecast for next year BLTE (Belite Bio)|OCUL - Expected earnings per share growth for next year|HROW - Net earnings per share growth forecast for next year|Expected earnings per share trend next year VRDN (Viridian Therapeutics)|LENZ (LENZ Therapeutics, Inc.) - Expected earnings per share growth for next year|Oculis Holding AG - Expected earnings per share trend next year|Net earnings per share growth forecast for next year eyepointpharma.com|Earnings growth forecast for next year Kodiak Sciences Inc.|Net earnings per share growth forecast for next year Aldeyra Therapeutics Inc. (ALDX)|Net earnings per share growth forecast for next year KALA (KALA BIO)|Net earnings per share growth forecast for next year opusgtx.com IRD|Expected earnings per share trend next year OKYO|ADVM: Expected earnings per share growth for next year|Expected earnings per share trend next year OTLK (Outlook Therapeutics)|CLSD: Earnings growth forecast for next year|NovaBay Pharmaceuticals Inc. - Expected earnings per share trend next year|Net earnings per share growth forecast for next year kiorapharma.com|eyenovia.com (EYEN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year GHSI|OCUP (Ocuphire) - Expected earnings per share trend next year|Earnings growth forecast for next year OPT (Opthea Ltd)